Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study (Q39323873)

11 September 2017

Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study (English)

1 reference

complex regional pain syndrome

11 September 2017

1 reference

Ralph-Thomas Kiefer

1

1 reference

11 September 2017

Peter Rohr

2

1 reference

11 September 2017

Annette Ploppa

3

1 reference

11 September 2017

Hans-Jürgen Dieterich

4

1 reference

11 September 2017

John Grothusen

5

1 reference

11 September 2017

Sandra Koffler

6

1 reference

11 September 2017

Karl-Heinz Altemeyer

7

1 reference

11 September 2017

Klaus Unertl

8

1 reference

11 September 2017

Robert J Schwartzman

9

1 reference

11 September 2017

5 February 2008

1 reference

11 September 2017

1 reference

11 September 2017

9

1 reference

11 September 2017

8

1 reference

11 September 2017

1173-1201

1 reference

Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study

11 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Complex regional pain syndrome is a disease of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Pathophysiology of complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Hemisensory impairment in patients with complex regional pain syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Interventional therapies in the management of complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Psychological and behavioral aspects of complex regional pain syndrome management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Pharmacologic management of complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Ketamine in chronic pain management: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Ketamine for perioperative pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The induction and maintenance of central sensitization is dependent on N -methyl-d-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

'Balanced analgesia' in the perioperative period: is there a place for ketamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

A randomized, double-blind, placebo-controlled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The NMDA-receptor antagonist ketamine abolishes neuropathic pain after epidural administration in a clinical case

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Successful treatment of a nine-year case of complex regional pain syndrome type-I (reflex sympathetic dystrophy) with intravenous ketamine-infusion therapy in a warfarin-anticoagulated adult female patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

A pilot open-label study of the efficacy of subanesthetic isomeric S(+)-ketamine in refractory CRPS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Controlled Sedation with Alphaxalone-Alphadolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The West Haven-Yale Multidimensional Pain Inventory (WHYMPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The Stanford Health Assessment Questionnaire: dimensions and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Comparison of the effects of MK-801, ketamine and memantine on responses of spinal dorsal horn neurones in a rat model of mononeuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Effect of ketamine on spinal cord nociceptive transmission in normal and monoarthritic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Ketamine, an N-methyl-D-aspartate receptor antagonist, inhibits the reflex responses to distension of the rat urinary bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Systemic ketamine inhibits hypersensitivity after surgery via descending inhibitory pathways in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The antiallodynic effect of NMDA antagonists in neuropathic pain outlasts the duration of the in vivo NMDA antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Complete recovery from intractable complex regional pain syndrome, CRPS-type I, following anesthetic ketamine and midazolam.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Central proinflammatory cytokines and pain enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Role of the immune system in chronic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The glycinergic control of spinal pain processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Ketamine potentiates cerebrocortical damage induced by the common anaesthetic agent nitrous oxide in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Revising a dogma: ketamine for patients with neurological injury?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2007.00402.X

10.1111/J.1526-4637.2007.00402.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference